Supreme Court E-Library
Information At Your Fingertips


  View printer friendly version

(NAR) VOL. III NO. 4 / OCTOBER - DECEMBER 1992

[ BFAD MEMORANDUM CIRCULAR NO. 18 S. 1992, July 28, 1992 ]

CONFIRMATION OF THE POLICY NOT TO REQUIRE PATENT CLEARANCE FOR THE REGISTRATION OF THE DRUG PRODUCTS



BFAD hereby confirms the policy not to require patent clearance for the registration of drug products.  Hence, all drug establishments are advised to exercise vigilance in avoiding infringement of patents and trade marks.

This policy, however, does not preclude any drug establishment from filing a petition or request for cancellation of a drug product registration on valid grounds or in cases of infringement, as the case may be.

Adopted: 28 July 1992

(SGD.) QUINTIN L. KINTANAR, M.D., PH.D.
Director — CESO I
© Supreme Court E-Library 2019
This website was designed and developed, and is maintained, by the E-Library Technical Staff in collaboration with the Management Information Systems Office.